Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells-Reference-Cited by-同舟云学术

Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells

Published:2015-05-27 Issue:30 Volume:6 Page:29833-29846
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Rigoni Micol¹²,Riganti Chiara³,Vitale Candida¹²,Griggio Valentina¹²,Campia Ivana³,Robino Marta¹,Foglietta Myriam¹²,Castella Barbara²,Sciancalepore Patrizia¹²,Buondonno Ilaria³,Drandi Daniela¹,Ladetto Marco¹,Boccadoro Mario¹,Massaia Massimo²⁴,Coscia Marta¹²

Affiliation:

1. Division of Hematology, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy

2. Center for Experimental Research and Medical Studies, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Torino, Italy

3. Department of Oncology, University of Torino, Torino, Italy

4. S.C. Ematologia e Terapie Cellulari, Azienda Ospedaliera Ordine Mauriziano di Torino, Torino, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Siglec-6 as a therapeutic target for cell migration and adhesion in chronic lymphocytic leukemia;Nature Communications;2024-06-18

2. Anti-tumor activity of selinexor in combination with antineoplastic agents in chronic lymphocytic leukemia;Scientific Reports;2023-10-07

3. Repositioning of HMG-CoA Reductase Inhibitors as Adjuvants in the Modulation of Efflux Pump-Mediated Bacterial and Tumor Resistance;Antibiotics;2023-09-20

4. Molecular mechanisms of ROS-modulated cancer chemoresistance and therapeutic strategies;Biomedicine & Pharmacotherapy;2023-09

5. β-Sitosterol as a Promising Anticancer Agent for Chemoprevention and Chemotherapy: Mechanisms of Action and Future Prospects;Advances in Nutrition;2023-09